Its total revenue from operations stood at Rs 2,228.8 crore, down by 4.4 per cent from Rs 2,333.1 crore for the year-ago period.
The company said it has received the tentative approval from USFDA to "market Mesalamine Suppositories for rectal use". Mesalamine is used to treat an inflammatory bowel disease, such as ulcerative colitis.
"It will be produced at the group's Topical plant here, the company added.
(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)
Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.
This website uses cookies.